279 related articles for article (PubMed ID: 33658991)
1. Comprehensive Analysis of CD4
Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
Front Immunol; 2020; 11():602014. PubMed ID: 33658991
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of CD4
Hyun YS; Lee YH; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
Front Immunol; 2021; 12():774491. PubMed ID: 35069546
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4
Lee YH; Hyun YS; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
Front Immunol; 2022; 13():897781. PubMed ID: 35967347
[No Abstract] [Full Text] [Related]
4. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
Front Immunol; 2019; 10():1568. PubMed ID: 31333679
[No Abstract] [Full Text] [Related]
5. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
Linner KM; Monroy C; Bach FH; Gehrz RC
Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8
Jo HA; Hyun SJ; Hyun YS; Lee YH; Kim SM; Baek IC; Sohn HJ; Kim TG
Immune Netw; 2023 Apr; 23(2):e17. PubMed ID: 37179751
[TBL] [Abstract][Full Text] [Related]
7. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8
Hyun SJ; Sohn HJ; Lee HJ; Lee SD; Kim S; Sohn DH; Hong CH; Choi H; Cho HI; Kim TG
Front Immunol; 2017; 8():1591. PubMed ID: 29209324
[TBL] [Abstract][Full Text] [Related]
9. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
McKinney DM; Southwood S; Hinz D; Oseroff C; Arlehamn CS; Schulten V; Taplitz R; Broide D; Hanekom WA; Scriba TJ; Wood R; Alam R; Peters B; Sidney J; Sette A
Immunogenetics; 2013 May; 65(5):357-70. PubMed ID: 23392739
[TBL] [Abstract][Full Text] [Related]
10. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
[TBL] [Abstract][Full Text] [Related]
11. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
12. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
13. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
14. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
Fontenot AP; Torres M; Marshall WH; Newman LS; Kotzin BL
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12717-22. PubMed ID: 11050177
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
[TBL] [Abstract][Full Text] [Related]
17. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
Fernandes AP; Foss MC; Donadi EA
Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
[TBL] [Abstract][Full Text] [Related]
18. Hardy-Weinberg testing for HLA class II (DRB1, DQA1, DQB1, and DPB1) loci in 26 human ethnic groups.
Chen JJ; Hollenbach JA; Trachtenberg EA; Just JJ; Carrington M; Rønningen KS; Begovich A; King MC; McWeeney S; Mack SJ; Erlich HA; Thomson G
Tissue Antigens; 1999 Dec; 54(6):533-42. PubMed ID: 10674966
[TBL] [Abstract][Full Text] [Related]
19. Associations of MHC class II alleles with insulin-dependent diabetes mellitus (IDDM) in patients from North India.
Rani R; Sood A; Lazaro AM; Stastny P
Hum Immunol; 1999 Jun; 60(6):524-31. PubMed ID: 10408802
[TBL] [Abstract][Full Text] [Related]
20. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]